Lauxera HealthTech
The sector expertise of a HealthTech specialist combined with the experience of Pergam managers
The objective of the fund is to invest in the HealthTech sector to obtain a performance greater than MSCI World HealthCare
Investment Strategy
HealthTech brings together fast-growing companies in the medical sector that use new technologies to offer sustainable solutions for prevention and care, linking health care and innovation.
The complementarity of two experts: Lauxera, an expert company in the field of HealthTech, brings its in-depth knowledge of the sector. Pergam constructs the portfolio, optimises the investment timing and the weight of the positions.
The investment process:
Extensive private equity due diligence. A concentrated portfolio of approximately 30 stocks.
Sustainable finance:
Lauxera HealthTech is an SFDR Article 8 fund.
Lauxera HealthTech is a sub-fund of the Pergam Funds SICAV in compliance with the UCITS Directive.
VL €
( part IE )
VL €
( part RE )
VL $
( part IU )
VL $
( part RU )
- Characteristics
- Performance
- Composition
- Documents
None for redemptions
First STOCKS lines in portfolio (as of 31/10/2023 )
No Data Found
Geographical distribution cash excluded (as of 31/10/2023 )
No Data Found
Performance is not constant over time and does not indicate future performance.
The sub-fund of the SICAV, which is incorporated under French law, is authorised for marketing in France. The risks and costs associated with investing in a UCITS are described in the Key Investor Information Document for this UCITS, which can be downloaded from this website. Pergam invites those concerned to take note of it. The Key Investor Information Document must be delivered to the subscriber prior to subscription.

Our other
funds